[1]
H. Jaber, S. et al. 2017. Formulation of Azithromycin Suspension as an Oral Dosage Form. Iraqi Journal of Pharmaceutical Sciences. 21, 1 (Mar. 2017), 61–69. DOI:https://doi.org/10.31351/vol21iss1pp61-69.